La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage.

Identifieur interne : 001032 ( PubMed/Curation ); précédent : 001031; suivant : 001033

The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage.

Auteurs : Hossein Aleyasin [Canada] ; Maxime W C. Rousseaux ; Maryam Phillips ; Raymond H. Kim ; Ross J. Bland ; Steve Callaghan ; Ruth S. Slack ; Matthew J. During ; Tak W. Mak ; David S. Park

Source :

RBID : pubmed:18003894

English descriptors

Abstract

Recent evidence has indicated that common mechanisms play roles among multiple neurological diseases. However, the specifics of these pathways are not completely understood. Stroke is caused by the interruption of blood flow to the brain, and cumulative evidence supports the critical role of oxidative stress in the ensuing neuronal death process. DJ-1 (PARK7) has been identified as the gene linked to early-onset familial Parkinson's disease. Currently, our work also shows that DJ-1 is central to death in both in Vitro and in Vivo models of stroke. Loss of DJ-1 increases the sensitivity to excitotoxicity and ischemia, whereas expression of DJ-1 can reverse this sensitivity and indeed provide further protection. Importantly, DJ-1 expression decreases markers of oxidative stress after stroke insult in Vivo, suggesting that DJ-1 protects through alleviation of oxidative stress. Consistent with this finding, we demonstrate the essential role of the oxidation-sensitive cysteine-106 residue in the neuroprotective activity of DJ-1 after stroke. Our work provides an important example of how a gene seemingly specific for one disease, in this case Parkinson's disease, also appears to be central in other neuropathological conditions such as stroke. It also highlights the important commonalities among differing neuropathologies.

DOI: 10.1073/pnas.0709379104
PubMed: 18003894

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:18003894

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage.</title>
<author>
<name sortKey="Aleyasin, Hossein" sort="Aleyasin, Hossein" uniqKey="Aleyasin H" first="Hossein" last="Aleyasin">Hossein Aleyasin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Ottawa Health Research Institute, Neuroscience Group, University of Ottawa, 451 Smyth Road, Ottawa, ON, Canada K1H 8M5.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Ottawa Health Research Institute, Neuroscience Group, University of Ottawa, 451 Smyth Road, Ottawa, ON</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Rousseaux, Maxime W C" sort="Rousseaux, Maxime W C" uniqKey="Rousseaux M" first="Maxime W C" last="Rousseaux">Maxime W C. Rousseaux</name>
</author>
<author>
<name sortKey="Phillips, Maryam" sort="Phillips, Maryam" uniqKey="Phillips M" first="Maryam" last="Phillips">Maryam Phillips</name>
</author>
<author>
<name sortKey="Kim, Raymond H" sort="Kim, Raymond H" uniqKey="Kim R" first="Raymond H" last="Kim">Raymond H. Kim</name>
</author>
<author>
<name sortKey="Bland, Ross J" sort="Bland, Ross J" uniqKey="Bland R" first="Ross J" last="Bland">Ross J. Bland</name>
</author>
<author>
<name sortKey="Callaghan, Steve" sort="Callaghan, Steve" uniqKey="Callaghan S" first="Steve" last="Callaghan">Steve Callaghan</name>
</author>
<author>
<name sortKey="Slack, Ruth S" sort="Slack, Ruth S" uniqKey="Slack R" first="Ruth S" last="Slack">Ruth S. Slack</name>
</author>
<author>
<name sortKey="During, Matthew J" sort="During, Matthew J" uniqKey="During M" first="Matthew J" last="During">Matthew J. During</name>
</author>
<author>
<name sortKey="Mak, Tak W" sort="Mak, Tak W" uniqKey="Mak T" first="Tak W" last="Mak">Tak W. Mak</name>
</author>
<author>
<name sortKey="Park, David S" sort="Park, David S" uniqKey="Park D" first="David S" last="Park">David S. Park</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:18003894</idno>
<idno type="pmid">18003894</idno>
<idno type="doi">10.1073/pnas.0709379104</idno>
<idno type="wicri:Area/PubMed/Corpus">001032</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001032</idno>
<idno type="wicri:Area/PubMed/Curation">001032</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001032</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage.</title>
<author>
<name sortKey="Aleyasin, Hossein" sort="Aleyasin, Hossein" uniqKey="Aleyasin H" first="Hossein" last="Aleyasin">Hossein Aleyasin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Ottawa Health Research Institute, Neuroscience Group, University of Ottawa, 451 Smyth Road, Ottawa, ON, Canada K1H 8M5.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Ottawa Health Research Institute, Neuroscience Group, University of Ottawa, 451 Smyth Road, Ottawa, ON</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Rousseaux, Maxime W C" sort="Rousseaux, Maxime W C" uniqKey="Rousseaux M" first="Maxime W C" last="Rousseaux">Maxime W C. Rousseaux</name>
</author>
<author>
<name sortKey="Phillips, Maryam" sort="Phillips, Maryam" uniqKey="Phillips M" first="Maryam" last="Phillips">Maryam Phillips</name>
</author>
<author>
<name sortKey="Kim, Raymond H" sort="Kim, Raymond H" uniqKey="Kim R" first="Raymond H" last="Kim">Raymond H. Kim</name>
</author>
<author>
<name sortKey="Bland, Ross J" sort="Bland, Ross J" uniqKey="Bland R" first="Ross J" last="Bland">Ross J. Bland</name>
</author>
<author>
<name sortKey="Callaghan, Steve" sort="Callaghan, Steve" uniqKey="Callaghan S" first="Steve" last="Callaghan">Steve Callaghan</name>
</author>
<author>
<name sortKey="Slack, Ruth S" sort="Slack, Ruth S" uniqKey="Slack R" first="Ruth S" last="Slack">Ruth S. Slack</name>
</author>
<author>
<name sortKey="During, Matthew J" sort="During, Matthew J" uniqKey="During M" first="Matthew J" last="During">Matthew J. During</name>
</author>
<author>
<name sortKey="Mak, Tak W" sort="Mak, Tak W" uniqKey="Mak T" first="Tak W" last="Mak">Tak W. Mak</name>
</author>
<author>
<name sortKey="Park, David S" sort="Park, David S" uniqKey="Park D" first="David S" last="Park">David S. Park</name>
</author>
</analytic>
<series>
<title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
<idno type="eISSN">1091-6490</idno>
<imprint>
<date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Biomarkers</term>
<term>Brain Ischemia (metabolism)</term>
<term>Brain Ischemia (pathology)</term>
<term>Cells, Cultured</term>
<term>Cysteine (genetics)</term>
<term>Cysteine (metabolism)</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Knockout</term>
<term>Microtubule-Associated Proteins (genetics)</term>
<term>Microtubule-Associated Proteins (metabolism)</term>
<term>Models, Biological</term>
<term>Oncogene Proteins (deficiency)</term>
<term>Oncogene Proteins (genetics)</term>
<term>Oncogene Proteins (metabolism)</term>
<term>Oxidation-Reduction</term>
<term>Oxidative Stress</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson Disease (metabolism)</term>
<term>Parkinson Disease (pathology)</term>
<term>Peroxiredoxins</term>
<term>Protein Deglycase DJ-1</term>
<term>Rats</term>
<term>Sensitivity and Specificity</term>
<term>Stroke (genetics)</term>
<term>Stroke (metabolism)</term>
<term>Stroke (pathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="deficiency" xml:lang="en">
<term>Oncogene Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Cysteine</term>
<term>Microtubule-Associated Proteins</term>
<term>Oncogene Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Cysteine</term>
<term>Microtubule-Associated Proteins</term>
<term>Oncogene Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Biomarkers</term>
<term>Peroxiredoxins</term>
<term>Protein Deglycase DJ-1</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Parkinson Disease</term>
<term>Stroke</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Brain Ischemia</term>
<term>Parkinson Disease</term>
<term>Stroke</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Brain Ischemia</term>
<term>Parkinson Disease</term>
<term>Stroke</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cells, Cultured</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Knockout</term>
<term>Models, Biological</term>
<term>Oxidation-Reduction</term>
<term>Oxidative Stress</term>
<term>Rats</term>
<term>Sensitivity and Specificity</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Recent evidence has indicated that common mechanisms play roles among multiple neurological diseases. However, the specifics of these pathways are not completely understood. Stroke is caused by the interruption of blood flow to the brain, and cumulative evidence supports the critical role of oxidative stress in the ensuing neuronal death process. DJ-1 (PARK7) has been identified as the gene linked to early-onset familial Parkinson's disease. Currently, our work also shows that DJ-1 is central to death in both in Vitro and in Vivo models of stroke. Loss of DJ-1 increases the sensitivity to excitotoxicity and ischemia, whereas expression of DJ-1 can reverse this sensitivity and indeed provide further protection. Importantly, DJ-1 expression decreases markers of oxidative stress after stroke insult in Vivo, suggesting that DJ-1 protects through alleviation of oxidative stress. Consistent with this finding, we demonstrate the essential role of the oxidation-sensitive cysteine-106 residue in the neuroprotective activity of DJ-1 after stroke. Our work provides an important example of how a gene seemingly specific for one disease, in this case Parkinson's disease, also appears to be central in other neuropathological conditions such as stroke. It also highlights the important commonalities among differing neuropathologies.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">18003894</PMID>
<DateCreated>
<Year>2007</Year>
<Month>11</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2008</Year>
<Month>01</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>11</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1091-6490</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>104</Volume>
<Issue>47</Issue>
<PubDate>
<Year>2007</Year>
<Month>Nov</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
<ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
</Journal>
<ArticleTitle>The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage.</ArticleTitle>
<Pagination>
<MedlinePgn>18748-53</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Recent evidence has indicated that common mechanisms play roles among multiple neurological diseases. However, the specifics of these pathways are not completely understood. Stroke is caused by the interruption of blood flow to the brain, and cumulative evidence supports the critical role of oxidative stress in the ensuing neuronal death process. DJ-1 (PARK7) has been identified as the gene linked to early-onset familial Parkinson's disease. Currently, our work also shows that DJ-1 is central to death in both in Vitro and in Vivo models of stroke. Loss of DJ-1 increases the sensitivity to excitotoxicity and ischemia, whereas expression of DJ-1 can reverse this sensitivity and indeed provide further protection. Importantly, DJ-1 expression decreases markers of oxidative stress after stroke insult in Vivo, suggesting that DJ-1 protects through alleviation of oxidative stress. Consistent with this finding, we demonstrate the essential role of the oxidation-sensitive cysteine-106 residue in the neuroprotective activity of DJ-1 after stroke. Our work provides an important example of how a gene seemingly specific for one disease, in this case Parkinson's disease, also appears to be central in other neuropathological conditions such as stroke. It also highlights the important commonalities among differing neuropathologies.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Aleyasin</LastName>
<ForeName>Hossein</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Ottawa Health Research Institute, Neuroscience Group, University of Ottawa, 451 Smyth Road, Ottawa, ON, Canada K1H 8M5.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rousseaux</LastName>
<ForeName>Maxime W C</ForeName>
<Initials>MW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Phillips</LastName>
<ForeName>Maryam</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Raymond H</ForeName>
<Initials>RH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bland</LastName>
<ForeName>Ross J</ForeName>
<Initials>RJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Callaghan</LastName>
<ForeName>Steve</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Slack</LastName>
<ForeName>Ruth S</ForeName>
<Initials>RS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>During</LastName>
<ForeName>Matthew J</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mak</LastName>
<ForeName>Tak W</ForeName>
<Initials>TW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Park</LastName>
<ForeName>David S</ForeName>
<Initials>DS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2007</Year>
<Month>11</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
<NlmUniqueID>7505876</NlmUniqueID>
<ISSNLinking>0027-8424</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015513">Oncogene Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.11.1.15</RegistryNumber>
<NameOfSubstance UI="D054464">Peroxiredoxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.2.-</RegistryNumber>
<NameOfSubstance UI="C503466">PARK7 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.2.-</RegistryNumber>
<NameOfSubstance UI="C404267">PARK7 protein, rat</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.2.-</RegistryNumber>
<NameOfSubstance UI="D000071617">Protein Deglycase DJ-1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K848JZ4886</RegistryNumber>
<NameOfSubstance UI="D003545">Cysteine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Int Rev Cytol. 2002;221:93-148</RefSource>
<PMID Version="1">12455747</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9103-8</RefSource>
<PMID Version="1">15181200</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Calcium. 2004 Sep-Oct;36(3-4):257-64</RefSource>
<PMID Version="1">15261481</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 1996 Feb;27(2):327-31; discussion 332</RefSource>
<PMID Version="1">8571432</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Biobehav Rev. 1997 Mar;21(2):121-8</RefSource>
<PMID Version="1">9062934</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 1997 Feb 13;231(2):509-13</RefSource>
<PMID Version="1">9070310</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2509-14</RefSource>
<PMID Version="1">9482916</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 1998 Oct 20;251(2):545-9</RefSource>
<PMID Version="1">9792810</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Biol. 2004 Nov;2(11):e327</RefSource>
<PMID Version="1">15502868</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2005 Mar 9;25(10):2504-12</RefSource>
<PMID Version="1">15758158</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5215-20</RefSource>
<PMID Version="1">15784737</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chronic Dis Can. 2004 Summer-Fall;25(3-4):138-46</RefSource>
<PMID Version="1">15841854</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2005 Jun 10;331(3):761-77</RefSource>
<PMID Version="1">15865932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Free Radic Biol Med. 2005 Aug 15;39(4):429-43</RefSource>
<PMID Version="1">16043015</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1140-9</RefSource>
<PMID Version="1">16115017</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Calcium. 2005 Sep-Oct;38(3-4):409-15</RefSource>
<PMID Version="1">16087231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13670-5</RefSource>
<PMID Version="1">16155123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14080-5</RefSource>
<PMID Version="1">16166266</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gene. 2005 Nov 21;361:133-9</RefSource>
<PMID Version="1">16203113</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12517-22</RefSource>
<PMID Version="1">16894167</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Neurol. 2006 Oct;201(2):324-34</RefSource>
<PMID Version="1">16740259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15091-6</RefSource>
<PMID Version="1">17015834</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Oct 19;443(7113):787-95</RefSource>
<PMID Version="1">17051205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 2007 Apr;38(4):1396</RefSource>
<PMID Version="1">17347469</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2007 May 4;282(18):13680-91</RefSource>
<PMID Version="1">17331951</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MMWR Morb Mortal Wkly Rep. 2007 May 18;56(19):469-74</RefSource>
<PMID Version="1">17510610</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2007 Jul;130(Pt 7):1787-98</RefSource>
<PMID Version="1">17535834</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Pharm Des. 2007;13(18):1875-86</RefSource>
<PMID Version="1">17584114</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2007 Jul 5;55(1):37-52</RefSource>
<PMID Version="1">17610816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gene. 2007 Oct 1;400(1-2):158-65</RefSource>
<PMID Version="1">17651920</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Res Exp Med (Berl). 1999 Dec;199(3):167-76</RefSource>
<PMID Version="1">10639700</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Free Radic Biol Med. 2000 Jan 1;28(1):13-7</RefSource>
<PMID Version="1">10656286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2000 Aug 18;275(33):25358-64</RefSource>
<PMID Version="1">10851232</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Free Radic Res. 2001 Sep;35(3):301-10</RefSource>
<PMID Version="1">11697128</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Free Radic Res. 2001 Dec;35(6):885-93</RefSource>
<PMID Version="1">11811539</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Atheroscler Rep. 2002 Jul;4(4):285-90</RefSource>
<PMID Version="1">12052279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods. 2002 Oct;28(2):158-67</RefSource>
<PMID Version="1">12413414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antioxid Redox Signal. 2003 Oct;5(5):597-607</RefSource>
<PMID Version="1">14580316</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO Rep. 2004 Feb;5(2):213-8</RefSource>
<PMID Version="1">14749723</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gene Med. 2004 Feb;6 Suppl 1:S212-22</RefSource>
<PMID Version="1">14978764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Mol Life Sci. 2004 Mar;61(6):657-68</RefSource>
<PMID Version="1">15052409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Biophys Res Commun. 2004 May 7;317(3):722-8</RefSource>
<PMID Version="1">15081400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 2004 Apr;24(4):351-71</RefSource>
<PMID Version="1">15087705</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Neurosci. 2004 Jun;11(5):501-6</RefSource>
<PMID Version="1">15177393</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2003 Jan 10;299(5604):256-9</RefSource>
<PMID Version="1">12446870</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003545" MajorTopicYN="N">Cysteine</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015513" MajorTopicYN="N">Oncogene Proteins</DescriptorName>
<QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054464" MajorTopicYN="N">Peroxiredoxins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000071617" MajorTopicYN="N">Protein Deglycase DJ-1</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC2141848</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>11</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2008</Year>
<Month>1</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2007</Year>
<Month>11</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">18003894</ArticleId>
<ArticleId IdType="pii">0709379104</ArticleId>
<ArticleId IdType="doi">10.1073/pnas.0709379104</ArticleId>
<ArticleId IdType="pmc">PMC2141848</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001032 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001032 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:18003894
   |texte=   The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:18003894" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022